15.91
+2.84%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Avantor
From its filings with the US Securities and Exchange Commission
Avantor is based in Radnor, Pennsylvania. Its shares trade on NYSE under the ticker AVTR. The SEC classifies its business as laboratory analytical instruments. In the fiscal year to 31 December 2025, it reported revenue of $6.55bn and a net loss of $530.2m. At that date it held total assets of $11.79bn and shareholders' equity of $5.57bn. By business, Proprietary brought in 52.6% of revenue, followed by Third-party at 47.4%.
At Avantor, everything we do is tied to our unique mission of setting science in motion to create a better world.
We are a leading global provider of mission-critical products and services to customers in the biopharma & healthcare, education & government, and advanced technologies & applied materials end markets. Our business model is grounded in supporting our customers from discovery to delivery and Avantor is embedded in virtually every stage of the most important research, scale-up and manufacturing activities in the industries we serve.
We work with customers across these sophisticated, science-driven industries that require innovation and adherence to the most demanding technical and regulatory requirements. Our customer-centric innovation model enables us to provide solutions for some of the most demanding applications, and we leverage our comprehensive offering and access to early-stage research to identify and develop content and solutions that ultimately become specified into our customers’ approved production platforms.
We go to market in two primary ways. First, in our channel business, VWR, we distribute consumables and equipment to laboratories around the world. Second, we manufacture proprietary products used in life sciences and medical technology applications.
Quoted from its 10-K, filed 11 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 17 May 2019
- Employees
- 13,500
- Website
- avantorsciences.com ↗
- Head office
- RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA, 19087
- Classification
- Laboratory Analytical Instruments
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Gregory SummeIndependent Chairman of the Board$329,975
- Mr. Emmanuel LignerPresident, Chief Executive Officer, Director, since 2025
- Mr. R. Brent JonesChief Financial Officer, Executive Vice President$3.9m
- Ms. Mary BlennExecutive Vice President, Chief Operating Officer
- Ms. Brittany HankamerChief Human Resources Officer, Executive Vice President
- Mr. Claudius SokenuExecutive Vice President, Chief Legal and Compliance Officer and Corporate Secretary$2.8m
- Mr. Christophe CouturierExecutive Vice President, AMEA
- Mr. Benoit GourdierExecutive Vice President - Bioscience Production$3.7m
- Ms. Kitty SahinExecutive Vice President - Strategy and Corporate Development
- Mr. Juan AndresIndependent Director$317,475
- Dr. John CarethersIndependent Director$312,475
- Mr. Simon DingemansIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 83
- Environment
- 82
- Social
- 74
- Governance
- 92
- Direct emissions (scope 1)
- 26,095 t
- Energy emissions (scope 2)
- 28,933 t
- Women in the workforce
- 45%
- Carbon reduction policy
- No
- Human rights policy
- Yes
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.